Related Experiment Video
Updated: Dec 18, 2025

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
Management of Autosomal Dominant Polycystic Kidney Disease (ADPKD) During Pregnancy: Risks and Challenges
Lucy McBride1, Catherine Wilkinson2, Shilpanjali Jesudason2,3
1Women's and Babies' Division, Women's and Children's Hospital, Adelaide, SA, Australia.
Insights
Autosomal dominant polycystic kidney disease (ADPKD) impacts many, causing kidney cysts and function loss. Managing ADPKD in pregnancy presents challenges for optimal maternal and fetal outcomes.
Area of Science:
- Nephrology
- Genetics
- Reproductive Medicine
Background:
- Autosomal dominant polycystic kidney disease (ADPKD) is a common genetic disorder affecting 1 in 1000 individuals.
- It is characterized by progressive renal cyst development, leading to kidney function decline and potential extra-renal manifestations like hepatic cysts and intracranial aneurysms.
- Pathogenic variants in the PKD1 or PKD2 genes are the primary cause of ADPKD.
Purpose of the Study:
- To review the advancements in ADPKD management, including genetic testing and novel therapeutics.
- To highlight the complexities and risks associated with renal disease in pregnancy for women with ADPKD.
- To outline the challenges faced by women with ADPKD and healthcare providers in optimizing care across pre-pregnancy, pregnancy, and postpartum periods.
Main Methods:
- Literature review of recent advancements in ADPKD diagnosis and treatment.
- Analysis of the impact of ADPKD on pregnancy outcomes.
- Discussion of clinical management strategies for pregnant women with ADPKD.
Main Results:
- Genetic testing and pre-implantation genetic diagnosis have improved ADPKD management.
- New therapeutic agents offer potential for better disease control.
- Pregnancy in women with ADPKD poses significant risks for both mother and fetus.
Conclusions:
- Modern advancements in ADPKD management offer new hope for patients.
- Careful planning and multidisciplinary management are crucial for pregnant women with ADPKD.
- Addressing the challenges in pre-pregnancy, pregnancy, and postpartum care is essential for improving outcomes.
Abstract:
Autosomal dominant polycystic kidney disease (ADPKD) affects up to 1 in 1000 people. The disease is characterized by the progressive development of cysts throughout the renal parenchyma due to inherited pathogenic variants in genes including PKD1 or PKD2 and eventually leads to gradual loss of renal function, along with manifestations in other organ systems such as hepatic cysts and intracranial aneurysms. ADPKD management has advanced considerably in recent years due to genetic testing availability, pre-implantation genetic diagnosis technology and new therapeutic agents. Renal disease in pregnancy is recognised as an important risk factor for adverse maternal and fetal outcome. Women with ADPKD and health professionals face multiple challenges in optimising outcomes during the pre-pregnancy, pregnancy and post-partum periods.
More Related Videos
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease II: Clinical Manifestations
Peritoneal Dialysis III: Nursing Management
Nephrotic Syndrome III : Nursing Management

